Literature DB >> 19139910

Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy.

Justin Zaghi1, Ben Goldenson, Mohammed Inayathullah, Albert S Lossinsky, Ava Masoumi, Hripsime Avagyan, Michelle Mahanian, Michael Bernas, Martin Weinand, Mark J Rosenthal, Araceli Espinosa-Jeffrey, Jean de Vellis, David B Teplow, Milan Fiala.   

Abstract

Neuronal accumulation of oligomeric amyloid-beta (Alphabeta) is considered the proximal cause of neuronal demise in Alzheimer disease (AD) patients. Blood-borne macrophages might reduce Abeta stress to neurons by immigration into the brain and phagocytosis of Alphabeta. We tested migration and export across a blood-brain barrier model, and phagocytosis and clearance of Alphabeta by AD and normal subjects' macrophages. Both AD and normal macrophages were inhibited in Alphabeta export across the blood-brain barrier due to adherence of Abeta-engorged macrophages to the endothelial layer. In comparison to normal subjects' macrophages, AD macrophages ingested and cleared less Alphabeta, and underwent apoptosis upon exposure to soluble, protofibrillar, or fibrillar Alphabeta. Confocal microscopy of stained AD brain sections revealed oligomeric Abeta in neurons and apoptotic macrophages, which surrounded and infiltrated congophilic microvessels, and fibrillar Abeta in plaques and microvessel walls. After incubation with AD brain sections, normal subjects' monocytes intruded into neurons and uploaded oligomeric Abeta. In conclusion, in patients with AD, macrophages appear to shuttle Abeta from neurons to vessels where their apoptosis may release fibrillar Abeta, contributing to cerebral amyloid angiopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139910      PMCID: PMC5650912          DOI: 10.1007/s00401-008-0481-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  53 in total

1.  Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.

Authors:  Nancy Q Liu; Albert S Lossinsky; Waldemar Popik; Xia Li; Chandrasekhar Gujuluva; Benjamin Kriederman; Jaclyn Roberts; Tatania Pushkarsky; Michael Bukrinsky; Marlys Witte; Martin Weinand; Milan Fiala
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier.

Authors:  M Fiala; D J Looney; M Stins; D D Way; L Zhang; X Gan; F Chiappelli; E S Schweitzer; P Shapshak; M Weinand; M C Graves; M Witte; K S Kim
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

Review 3.  The role of microglia and macrophages in the pathophysiology of the CNS.

Authors:  G Stoll; S Jander
Journal:  Prog Neurobiol       Date:  1999-06       Impact factor: 11.685

4.  Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF).

Authors:  John A Hamilton; Genevieve Whitty; Anthony R White; Michael F Jobling; Andrew Thompson; Colin J Barrow; Roberto Cappai; Konrad Beyreuther; Colin L Masters
Journal:  Brain Res       Date:  2002-06-14       Impact factor: 3.252

5.  Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model.

Authors:  M Fiala; L Zhang; X Gan; B Sherry; D Taub; M C Graves; S Hama; D Way; M Weinand; M Witte; D Lorton; Y M Kuo; A E Roher
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

6.  Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.

Authors:  Donna M Wilcock; Giovanni DiCarlo; Debbi Henderson; Jennifer Jackson; Keisha Clarke; Kenneth E Ugen; Marcia N Gordon; Dave Morgan
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 8.  Autophagy, amyloidogenesis and Alzheimer disease.

Authors:  Ralph A Nixon
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

9.  Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.

Authors:  Jerzy Wegiel; Izabela Kuchna; Krzysztof Nowicki; Janusz Frackowiak; Bozena Mazur-Kolecka; Humi Imaki; Jarek Wegiel; Pankaj D Mehta; Wayne P Silverman; Barry Reisberg; Mony Deleon; Thomas Wisniewski; Tuula Pirttilla; Harry Frey; Terho Lehtimäki; Tarmo Kivimäki; Frank E Visser; Wouter Kamphorst; Anna Potempska; David Bolton; Julia R Currie; David L Miller
Journal:  Acta Neuropathol       Date:  2007-01-20       Impact factor: 17.088

10.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Authors:  Milan Fiala; Philip T Liu; Araceli Espinosa-Jeffrey; Mark J Rosenthal; George Bernard; John M Ringman; James Sayre; Laura Zhang; Justin Zaghi; Sheila Dejbakhsh; Ben Chiang; James Hui; Michelle Mahanian; Anita Baghaee; Pamela Hong; John Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

View more
  43 in total

1.  Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

Authors:  Aaron Y Lai; Joanne McLaurin
Journal:  Future Neurol       Date:  2012-03-01

2.  Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function.

Authors:  Emalick G Njie; Ellen Boelen; Frank R Stassen; Harry W M Steinbusch; David R Borchelt; Wolfgang J Streit
Journal:  Neurobiol Aging       Date:  2010-07-02       Impact factor: 4.673

3.  Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment.

Authors:  Henry M Olivera-Perez; Larry Lam; Johnny Dang; Weilan Jiang; Fabian Rodriguez; Elizabeth Rigali; Sarah Weitzman; Verna Porter; Liudmilla Rubbi; Marco Morselli; Matteo Pellegrini; Milan Fiala
Journal:  FASEB J       Date:  2017-06-20       Impact factor: 5.191

Review 4.  Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.

Authors:  Milan Fiala; Gijs Kooij; Karen Wagner; Bruce Hammock; Matteo Pellegrini
Journal:  FASEB J       Date:  2017-04-18       Impact factor: 5.191

5.  Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier.

Authors:  Michael J Bernas; Filipa L Cardoso; Sarah K Daley; Martin E Weinand; Alexandre R Campos; António J Gonçalves Ferreira; James B Hoying; Marlys H Witte; Dora Brites; Yuri Persidsky; Servio H Ramirez; Maria A Brito
Journal:  Nat Protoc       Date:  2010-06-10       Impact factor: 13.491

6.  Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.

Authors:  Hongguang Chen; Min Wang; Aihong Jiao; Guotai Tang; Wei Zhu; Peng Zou; Tuo Li; Guangqiang Cui; Peiyou Gong
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 7.  Developmental aspects of the intracerebral microvasculature and perivascular spaces: insights into brain response to late-life diseases.

Authors:  Miguel Marín-Padilla; David S Knopman
Journal:  J Neuropathol Exp Neurol       Date:  2011-12       Impact factor: 3.685

8.  IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.

Authors:  Milan Fiala; Madhuri Chattopadhay; Antonio La Cava; Eric Tse; Guanghao Liu; Elaine Lourenco; Ascia Eskin; Philip T Liu; Larry Magpantay; Stephen Tse; Michelle Mahanian; Rachel Weitzman; Jason Tong; Caroline Nguyen; Tiffany Cho; Patrick Koo; James Sayre; Otoniel Martinez-Maza; Mark J Rosenthal; Martina Wiedau-Pazos
Journal:  J Neuroinflammation       Date:  2010-11-09       Impact factor: 8.322

Review 9.  Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease.

Authors:  Milan Fiala; Robert Veerhuis
Journal:  Exp Gerontol       Date:  2009-08-21       Impact factor: 4.032

10.  Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients.

Authors:  Larry Lam; Lydia Chin; Ramesh C Halder; Bien Sagong; Sam Famenini; James Sayre; Dennis Montoya; Liudmilla Rubbi; Matteo Pellegrini; Milan Fiala
Journal:  FASEB J       Date:  2016-07-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.